You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Exercise Disclosure
Savage Brian · SEC Form 4 · Filed Sep 22, 2026
Exercise
Calculated transaction value
$156.25K
Savage Brian Interim Chief Legal Officer
TEVA
Transaction date
Sep 18, 2026
Public filing date
Sep 22, 2026
Filing lag
Filed 4 days later
TEVA daily price context
Close on/before transaction
$38.98
Sep 18, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (right to buy) on Ordinary Shares
- Quantity / price
- 4,503 shares @ $34.7
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-398105
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$597.72K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Sep 18, 2026 | $156.25K |
| Teva Pharmaceutical Industries Ltd TEVA | Sale | Sep 18, 2026 | $174.22K |
| Teva Pharmaceutical Industries Ltd TEVA | Sale | Sep 18, 2026 | $12.15K |
| Teva Pharmaceutical Industries Ltd TEVA | Sale | Sep 18, 2026 | $98.84K |
| Teva Pharmaceutical Industries Ltd TEVA Current | Exercise | Sep 18, 2026 | $156.25K |